PMA device
ReSure Sealant
Ocular Therapeutix, Inc. · Ophthalmic Sealant (PFZ, Class III) · First FDA decision Oct 2, 2014, newest Nov 2, 2021Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
3
Naming "ReSure"
MAUDE reports
2
Brand "ReSure", since 2015
PubMed studies
17
Mentioning "ReSure"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ReSure Sealant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- ReSure SealantPMA supplement
P130004-S011 · Decided Nov 2, 2021 · 145 days after receipt · Normal 180 Day Track No User Fee
Device type: Ophthalmic Sealant (PFZ) · Ophthalmology
- ReSure SealantPMA supplement
P130004-S008 · Decided May 5, 2020 · 146 days after receipt · Normal 180 Day Track No User Fee
Device type: Ophthalmic Sealant (PFZ) · Ophthalmology
- RESURE SEALANTPMA supplement
P130004-S002 · Decided Jul 21, 2016 · 895 days after receipt · Normal 180 Day Track No User Fee
Device type: Ophthalmic Sealant (PFZ) · Ophthalmology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ReSure", any status and sponsor, newest update first.
- OTX-14-002: Device Exposure RegistryWithdrawn
Ocular Therapeutix, Inc.Not on our public-company list
NCT02309736 · 0 participants · Primary completion Apr 2020
Device: ReSure Sealant · For: Endophthalmitis
- ReSure Sealant Pivotal StudyPivotal-lookingCompleted
Ocular Therapeutix, Inc.Not on our public-company list
NCT01498224 · 488 participants · Start Dec 2011 · Primary completion Nov 2012
Device: ReSure Sealant · For: Cataract Surgery Incision Leak
Sites: Jacksonville, Florida
- ReSure Sealant Post Approval StudyCompleted
Ocular Therapeutix, Inc.Not on our public-company list
NCT02310815 · 626 participants · Start Dec 2014 · Primary completion Feb 2016
Device: ReSure Sealant · For: Adverse Events
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ReSure", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 2 injury, 0 death
Whole product code PFZ
2 reports: 0 malfunction, 2 injury, 0 death
Newest reports for this brand
- RESURE SEALANTInjury
3008477155-2018-00001 · Received Feb 23, 2018
Device type: Ophthalmic Sealant (PFZ)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Endophthalmitis
- RESURE SEALANTInjury
3008477155-2018-00002 · Received Feb 23, 2018
Device type: Ophthalmic Sealant (PFZ)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Endophthalmitis
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ReSure"[tiab]. The summary above synthesizes these.
- Hydrogel Sealant for Closure of Clear Corneal Incisions in Combined Glaucoma Procedures.
Machiele RD, Guduru A, Herndon LW · Clin Ophthalmol · 2022
- Corneal Sealants in Clinical Use: A Systematic Review.
Tan J, Foster LJR, Watson SL · Curr Eye Res · 2020Research Support, Non-U.S. Gov't, Systematic Review
- Assessment of the Retinal Toxicity and Sealing Strength of Tissue Adhesives.
Sharabura A, Chancellor J, Siddiqui MZ, et al. · Curr Eye Res · 2022
- Hydrogel-based ocular drug delivery systems.
Sabbagh F, Zargarian SS, Kosik-Kozio A, et al. · J Mater Chem B · 2025Review
- Minimally Invasive Pterygium Surgery: Sutureless Excision with Amniotic Membrane and Hydrogel Sealant.
Bondalapati S, Ambati B · Case Rep Ophthalmol · 2016Case Reports
- Recalcitrant Epithelial Ingrowth After SMILE Treated With a Hydrogel Ocular Sealant.
Thulasi P, Kim SW, Shetty R, et al. · J Refract Surg · 2015Case Reports, Research Support, Non-U.S. Gov't
- Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye.
Cheng KJ, Hsieh CM, Nepali K, et al. · J Med Chem · 2020Research Support, Non-U.S. Gov't, Review
- Burst Pressures in Eyes with Clear Corneal Incisions Treated with ReSure Glue.
Shehata AEM, Kambhampati SP, Wang J, et al. · J Ophthalmol · 2021
- ReSure Sealant for Pars Plana Vitrectomy Wound Closure.
Ho VY, Shah GK, Liu EM · Ophthalmic Surg Lasers Imaging Retina · 2015Case Reports
- Use of a hydrogel sealant in epithelial ingrowth removal after laser in situ keratomileusis.
Ramsook SS, Hersh PS · J Cataract Refract Surg · 2015Case Reports, Research Support, Non-U.S. Gov't
- Hydrogel ocular sealant for clear corneal incisions in cataract surgery.
Nallasamy N, Grove KE, Legault GL, et al. · J Cataract Refract Surg · 2017
- Effect on Gel Formation Time of Adding Topical Ophthalmic Medications to ReSure Sealant, an In Situ Hydrogel.
Mah FS · J Ocul Pharmacol Ther · 2016Research Support, Non-U.S. Gov't
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.